Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

912

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

April 30, 2011

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

exenatide once weekly

subcutaneous injection, 2mg, once weekly

DRUG

liraglutide

subcutaneous injection, forced titration to 1.8mg, once daily

Trial Locations (108)

Unknown

Research Site, Buenos Aires

Research site, Mendoza

Research Site, Rosario

Research Site, Box Hill

Research Site, Geelong

Research Site, Keswick

Research Site, Vienna

Research site, Bonheiden

Research Site, Edegem

Research Site, Genk

Research Site, Leuven

Research Site, Liège

Research Site, Charlottetown

Research Site, Gatineau

Research Site, Ottawa

Research Site, Sherbrooke

Research Site, Vancouver

Research Site, Victoria

Research Site, Windsor

Research Site, Winnipeg

Research Site, Brandýs nad Labem

Research Site, Prague

Research Site, Přerov

Research Site, Grenoble

Research Site, Le Creuzot

Research Site, Marseille

Research Site, Paris

Research Site, Poitiers

Research Site, Reims

Research Site, Strasbourg

Research Site, Bad Staffelstein

Research Site, Beckum

Research Site, Biberach

Research Site, Datteln

Research Site, Dresden

Research Site, Essen

Research Site, Ludwigshafen

Research Site, Mainz

Research Site, Meissen

Research Site, Münster

Research Site, Regensburg

Research Site, Riesa

Research Site, Stuttgart

Research Site, Athens

Research Site, Cholargós

Research Site, Pátrai

Research Site, Békéscsaba

Research Site, Budapest

Research Site, Makó

Research Site, Mosonmagyaróvár

Research Site, Nagykanizsa

Research Site, Székesfehérvár

Research Site, Aligarh

Research Site, Bangalore

Research Site, Chennai

Research Site, Coimbatore

Research Site, Hyderabad

Research Site, Indore

Research Site, Karnal/Haryana

Research site, Karnataka

Research Site, Mumbai

Research Site, Pune

Research Site, Beersheba

Research Site, Haifa

Research Site, Jerusalem

Research Site, Raanana

Research Site, Bari

Research Site, Cagliari

Research Site, Catanzaro

Research Site, Chieti

Research Site, Napoli

Research Site, Roma

Research Site, Treviglio

Research Site, Guadalajara

Research Site, México

Research Site, Monterrey

Research Site, Bialystok

Research Site, Krakow

Research Site, Lodz

Research Site, Poznan

Research site, Rzeszów

Research Site, Warsaw

Research site, Bucharest

Research site, Galati

Research site, Iași

Research site, Oradea

Research Site, Bratislava

Research Site, Košice

Research Site, Malacky

Research Site, Martin

Research Site, Halfway House

Research Site, Johannesburg

Research Site, Kempton Park

Research Site, Parktown

Research Site, Pretoria

Research Site, Seoul

Research Site, Ulsan

Research Site, Alicante

Research Site, Alzira

Research Site, Bilbao

Research Site, Madrid

Research Site, Majadahonda

Research Site, Teruel

Research Site, Changhua

Research Site, Taichung

Research Site, Xindian

Research Site, Yung-Kang, Tainan

Research Site, Zhonghe

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

AstraZeneca

INDUSTRY